Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 143612-79-7
2. 3-(4-chlorbutyl)-1h-indol-5-carbonitril
3. 3-(4-chlorobutyl)indole-5-carbonitrile
4. 1h-indole-5-carbonitrile, 3-(4-chlorobutyl)-
5. 3-(4-chlorobutyl)-5-cyanoindole
6. L6dng55pbh
7. Unii-l6dng55pbh
8. Schembl3082624
9. Dtxsid70432273
10. 3-(4-chloro-butyl)-5-cyanoindole
11. Bcp06422
12. Cs-m1251
13. Cl3519
14. Mfcd09833261
15. Zinc22010755
16. Akos015924756
17. Ac-25875
18. As-19269
19. Da-18262
20. 3-(4-chlorobutyl)-1h-indol-5-carbonitrile
21. Am20020489
22. Ft-0696598
23. A850798
24. A1-00284
25. J-510671
| Molecular Weight | 232.71 g/mol |
|---|---|
| Molecular Formula | C13H13ClN2 |
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 4 |
| Exact Mass | 232.0767261 g/mol |
| Monoisotopic Mass | 232.0767261 g/mol |
| Topological Polar Surface Area | 39.6 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 270 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A 3-4-Chlorobutyl-1H-Indole-5-Carbonitrile manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 3-4-Chlorobutyl-1H-Indole-5-Carbonitrile, including repackagers and relabelers. The FDA regulates 3-4-Chlorobutyl-1H-Indole-5-Carbonitrile manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 3-4-Chlorobutyl-1H-Indole-5-Carbonitrile API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 3-4-Chlorobutyl-1H-Indole-5-Carbonitrile supplier is an individual or a company that provides 3-4-Chlorobutyl-1H-Indole-5-Carbonitrile active pharmaceutical ingredient (API) or 3-4-Chlorobutyl-1H-Indole-5-Carbonitrile finished formulations upon request. The 3-4-Chlorobutyl-1H-Indole-5-Carbonitrile suppliers may include 3-4-Chlorobutyl-1H-Indole-5-Carbonitrile API manufacturers, exporters, distributors and traders.
3-4-Chlorobutyl-1H-Indole-5-Carbonitrile Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 3-4-Chlorobutyl-1H-Indole-5-Carbonitrile GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 3-4-Chlorobutyl-1H-Indole-5-Carbonitrile GMP manufacturer or 3-4-Chlorobutyl-1H-Indole-5-Carbonitrile GMP API supplier for your needs.
A 3-4-Chlorobutyl-1H-Indole-5-Carbonitrile CoA (Certificate of Analysis) is a formal document that attests to 3-4-Chlorobutyl-1H-Indole-5-Carbonitrile's compliance with 3-4-Chlorobutyl-1H-Indole-5-Carbonitrile specifications and serves as a tool for batch-level quality control.
3-4-Chlorobutyl-1H-Indole-5-Carbonitrile CoA mostly includes findings from lab analyses of a specific batch. For each 3-4-Chlorobutyl-1H-Indole-5-Carbonitrile CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
3-4-Chlorobutyl-1H-Indole-5-Carbonitrile may be tested according to a variety of international standards, such as European Pharmacopoeia (3-4-Chlorobutyl-1H-Indole-5-Carbonitrile EP), 3-4-Chlorobutyl-1H-Indole-5-Carbonitrile JP (Japanese Pharmacopeia) and the US Pharmacopoeia (3-4-Chlorobutyl-1H-Indole-5-Carbonitrile USP).
LOOKING FOR A SUPPLIER?
